Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.

Inclusion criteria

• Patient hospitalized in the rheumatology department
• Patient with acute pain in the context of a non-cancerous, non-traumatic, high-energy musculoskeletal pathology
• Patient for whom a prescription of strong opioid derivatives is initiated in rheumatology or patient for whom a prescription of strong opioid derivatives is maintained in rheumatology if the initial prescription has a maximum duration of 30 consecutive days prior to inclusion

Exclusion criteria

• Patient with cancer or fibromyalgia already diagnosed at inclusion
• Patient with poor French language skills
• Taking a strong opioid treatment for more than 30 consecutive days prior to inclusion
• Person judged by the prescriber or pharmacist as not autonomous for the management of strong opioid treatment
• Patient already included in the study